The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical OutcomesRadhia M’kacher, Patrice Carde, Mustafa Al Jawhari et al.|Cancers|2018Cited by 22
A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic miceAlexandre Quilbé, Nadira Delhem|Frontiers in Immunology|2023Cited by 7